AVIDITY BIOSCIENCES
Avidity Biosciences, Inc. is pioneering a new class of oligonucleotide-based therapies called AOCs designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Avidity utilizes its proprietary AOC platform to design, engineer and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide therapies in order to access previously undruggable tissue and cell types and more eff... ectively target underlying genetic drivers of diseases. Avidity's lead product candidate, AOC 1001, is designed to treat myotonic dystrophy type 1, and its four other muscle programs are focused on the treatment of muscle atrophy, Duchenne muscular dystrophy, facioscapulohumeral muscular dystrophy and Pompe disease. In addition to its muscle franchise, Avidity has development efforts focused on immune and other cell types.
AVIDITY BIOSCIENCES
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2013-01-01
Address:
La Jolla, California, United States
Country:
United States
Website Url:
http://www.aviditybiosciences.com
Total Employee:
11+
Status:
Active
Total Funding:
140.07 M USD
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series C - Avidity Biosciences
Takeda Ventures
Takeda Ventures investment in Series C - Avidity Biosciences
Eli Lilly
Eli Lilly investment in Series C - Avidity Biosciences
Logos Capital
Logos Capital investment in Series C - Avidity Biosciences
Partner Fund Management
Partner Fund Management investment in Series C - Avidity Biosciences
CureDuchenne Ventures
CureDuchenne Ventures investment in Series C - Avidity Biosciences
RTW Investments LLC
RTW Investments LLC investment in Series C - Avidity Biosciences
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Avidity Biosciences
Brace Pharma
Brace Pharma investment in Series C - Avidity Biosciences
Alethea Capital Management
Alethea Capital Management investment in Series C - Avidity Biosciences
Key Employee Changes
Official Site Inspections
http://www.aviditybiosciences.com Semrush global rank: 2.09 M Semrush visits lastest month: 9.87 K
- Host name: 129.177.197.104.bc.googleusercontent.com
- IP address: 104.197.177.129
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York